🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Synopsys Refurbishes RSoft Photonic Component Design Suite

Published 12/17/2018, 10:04 PM
Updated 07/09/2023, 06:31 AM
INTC
-
GEN
-
CACI
-
SNPS
-

Synopsys, Inc. (NASDAQ:SNPS) has introduced features in the version 2018.12 of the Synopsys RSoft Photonic Component Design Suite, which will help the upgrade of optics design used in augmented reality (AR) and virtual reality (VR) systems.

Reportedly, the latest release will support Synopsys’ optical design workflow for nano-textured diffractive optical elements that allow functionality of slick, slimmer, smaller and lightweight AR/VR devices flaunting enhanced visuals and virtual feel.

The enhancement of RSoft Bidirectional Scattering Distribution Function (BSDF) in the brand new version will provide greater design flexibility and speed.

Synopsys’ management was quoted saying, “With the LightTools and RSoft products' multi-domain simulation approach that combines macro- and nano-scale optical engineering, designers can create AR/VR models that provide end users with a superior sense of display immersion and visual comfort."

Synopsys acquired RSoft Design Group in May 2012. The company has augmented the CODE V and LightTools product lines with the addition of RSoft products that enable it to provide a full spectrum of photonic and optical design solutions.

Notably, the RSoft product suite is used to design, optimize and simulate optical telecommunication devices, optical components used in semiconductor manufacturing and nano-scale optical structures.

The solutions assist engineers to design and optimize the optical components and systems found in fiber optic networks, semiconductor lithography equipment, silicon optical chips and LEDs.

Notably, the company’s strategy to deliver a stream of innovative products for capitalizing on the emerging opportunities is aiding it to generate a large number of competitive wins and build significant customer relationships.

We therefore believe that with the surging popularity of AR/VR systems, Synopsys’s focus on addressing the key challenges in designing the same will help it scale new heights.

Zacks Rank & Other Stocks to Consider

Synopsys currently sports a Zacks Rank #1 (Buy). Some other top-ranked stocks in the broader Computer and Technology sector are CACI International (NYSE:CACI) , Intel (NASDAQ:INTC) and Symantec Corporation (NASDAQ:SYMC) , each sporting the same solid Zacks Rank of 1 as Synopsys. You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth rate for CACI, Intel and Symantec is projected at 10%, 8.42% and 7.9%, respectively.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



CACI International, Inc. (CACI): Free Stock Analysis Report

Symantec Corporation (SYMC): Free Stock Analysis Report

Synopsys, Inc. (SNPS): Free Stock Analysis Report

Intel Corporation (INTC): Free Stock Analysis Report

Original post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.